niacin and framycetin
niacin has been researched along with framycetin in 38 studies
Research
Studies (38)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 32 (84.21) | 18.7374 |
1990's | 2 (5.26) | 18.2507 |
2000's | 1 (2.63) | 29.6817 |
2010's | 3 (7.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Campillo, NE; Guerra, A; Páez, JA | 1 |
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
Scanu, AM | 1 |
Brewer, HB; Gurakar, A; Hoeg, JM; Kostner, G; Papadopoulos, NM | 1 |
Kostner, GM | 1 |
Brown, WV; Karmally, W; Smith, DA | 1 |
Kane, JP; Malloy, MJ | 2 |
Blum, CB; Levy, RI | 1 |
Nikkilä, EA; Tikkanen, MJ | 1 |
Perry, RS | 1 |
Havel, RJ; Kane, JP | 1 |
Malinow, MR | 1 |
Gotto, AM; Jones, PH; Scott, LW | 1 |
Bailey, KR; Brewer, HB; Hoeg, JM; Maher, MB | 1 |
Stuyt, PM | 1 |
Parker, F | 1 |
Bailey, KR; Bou, E; Brewer, HB; Gregg, RE; Hoeg, JM; Maher, MB; Pikus, AM; Sprecher, DL; Susser, JK; Zech, LA | 1 |
Azarnoff, DL; Saunders, RN | 1 |
LUTZ, A | 1 |
FABRE, M; GERNEZ-RIEUX, C; TACQUET, A; VOISIN, C | 1 |
CAYRE, RM; VIALLIER, J | 1 |
GOLDSMITH, GA; HAMILTON, JG; MILLER, ON | 1 |
HEYDEN, S | 1 |
BROWN, RL; EVANS, JB | 1 |
MARKIEWICZ, M | 1 |
YASUGI, T | 1 |
MOSELEY, V | 1 |
DELAEY, P; HOOFT, C; SNOECK, J; TIMMERMANS, J | 2 |
MENESESHOYOS, J | 1 |
FOIS, A; LECCHINI, L | 1 |
GOLDSMITH, GA | 1 |
LAHESMAA, R; MARKKANEN, T | 1 |
Reviews
10 review(s) available for niacin and framycetin
Article | Year |
---|---|
The affection of lipoprotein-a by lipid lowering drugs.
Topics: Arteriosclerosis; Bezafibrate; Cholestyramine Resin; Hormones; Humans; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Neomycin; Niacin; Nicotinic Acids; Stanozolol | 1988 |
When to treat hyperlipidemia.
Topics: Animals; Arteriosclerosis; Cholesterol; Cholestyramine Resin; Clofibrate; Colestipol; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Neomycin; Niacin; Pentanoic Acids; Risk Factors; Triglycerides | 1988 |
Contemporary recommendations for evaluating and treating hyperlipidemia.
Topics: Clofibrate; Dextrothyroxine; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipids; Lipoproteins; Lovastatin; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Phenotype; Probucol | 1986 |
Treatment of hypercholesterolemia.
Topics: Animals; Cholestyramine Resin; Clofibrate; Colestipol; Cricetinae; Dogs; Drug Therapy, Combination; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Mice; Middle Aged; Neomycin; Niacin; Pentanoic Acids; Pregnancy; Probucol; Rats | 1986 |
The diagnosis and management of hyperlipidemia.
Topics: Adolescent; Adult; Child; Child, Preschool; Cholesterol; Cholestyramine Resin; Chylomicrons; Clofibrate; Colestipol; Coronary Disease; Dextrothyroxine; Dietary Fats; Gemfibrozil; Humans; Hyperlipidemia, Familial Combined; Hyperlipidemias; Hyperlipoproteinemia Type I; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemia Type V; Lipoproteins; Lipoproteins, LDL; Neomycin; Niacin; Pentanoic Acids; Probucol; Receptors, LDL; Triglycerides | 1986 |
Treatment of hypercholesterolemia.
Topics: Cholestyramine Resin; Colestipol; Drug Therapy, Combination; Heterozygote; Homozygote; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols; Thyroxine | 1982 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
[DRUGS LOWERING THE CHOLESTEROL LEVEL IN THE BLOOD].
Topics: Antimetabolites; Arteriosclerosis; Ascorbic Acid; Cholesterol; Choline; Corrinoids; Ethyl Biscoumacetate; Heparin; Humans; Hypercholesterolemia; Iodoacetates; Lipotropic Agents; Magnesium Sulfate; Neomycin; Niacin; Nicotinic Acids; Progesterone; Pyridoxine; Thyroxine; Triparanol; Vitamin B 12 | 1963 |
[MECHANISM OF ACTION OF LIPEMIA-CLEARING PREPARATIONS].
Topics: Dextrans; Edetic Acid; Heparin; Hyperlipidemias; Lipoprotein Lipase; Neomycin; Niacin; Nicotinic Acids; Pyridoxine; Thyroid Gland | 1963 |
THE INTERRELATIONS BETWEEN CHOLESTEROL AND OTHER LIPIDS. II. A REVIEW.
Topics: Arteriosclerosis; Cholesterol; Edetic Acid; Estrogens; Fats, Unsaturated; Heparin; Humans; Hypercholesterolemia; Ion Exchange Resins; Lipids; Neomycin; Niacin; Nicotinic Acids; Sterols; Testosterone; Thyroid Hormones; Triparanol; Vitamin E | 1964 |
Trials
2 trial(s) available for niacin and framycetin
Article | Year |
---|---|
Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin.
Topics: Adult; Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Clinical Trials as Topic; Drug Therapy, Combination; Female; Humans; Hyperlipoproteinemia Type II; Lipoproteins; Male; Middle Aged; Neomycin; Niacin; Patient Compliance | 1984 |
Current status of drugs used to treat hyperlipoproteinemias.
Topics: Aminosalicylic Acid; Cholestyramine Resin; Clinical Trials as Topic; Colestipol; Enzyme Induction; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoproteins, HDL; Lipoproteins, LDL; Neomycin; Niacin; Nicotinic Acids; Probucol; Sitosterols | 1982 |
Other Studies
27 other study(ies) available for niacin and framycetin
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Lp(a): a link between thrombosis and atherosclerosis.
Topics: Adult; Arteriosclerosis; Child; Fatty Acids, Omega-3; Humans; Hyperlipoproteinemias; Hypolipidemic Agents; Lipoprotein(a); Lipoproteins; Mass Screening; Neomycin; Niacin; Risk Factors; Thrombosis | 1992 |
Choice of cholesterol-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Fish Oils; Gemfibrozil; Humans; Lovastatin; Neomycin; Niacin; Probucol | 1991 |
Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.
Topics: Adult; Aged; Cardiovascular Diseases; Cholesterol, LDL; Female; Humans; Hyperlipoproteinemia Type II; Lipids; Lipoprotein(a); Lipoproteins; Lipoproteins, VLDL; Male; Middle Aged; Neomycin; Niacin | 1985 |
Treating hyperlipidemia, Part III: Drug therapy.
Topics: Aged; Enzyme Inhibitors; Gemfibrozil; Heptanoic Acids; Humans; Hypercholesterolemia; Hyperlipidemias; Hypolipidemic Agents; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Pravastatin | 1987 |
Rational drug therapy of the hyperlipoproteinemias, Part II.
Topics: Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Female; Fish Oils; Gemfibrozil; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperlipoproteinemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Probucol | 1986 |
Current pharmacologic treatment of elevated serum cholesterol.
Topics: Adult; Anticholesteremic Agents; Cholesterol; Cholesterol, LDL; Cholestyramine Resin; Clofibrate; Colestipol; Drug Tolerance; Female; Gemfibrozil; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Pentanoic Acids; Probucol; Simvastatin; Triglycerides | 1987 |
Adverse effects of the treatment for hyperlipidemia.
Topics: Anion Exchange Resins; Anticholesteremic Agents; Bibliographies as Topic; Clofibrate; Diet; Drug Therapy, Combination; Gemfibrozil; Humans; Hyperlipidemias; Hypolipidemic Agents; Male; Neomycin; Niacin; Pentanoic Acids; Physical Exertion; Probucol; Risk | 1986 |
Comparison of six pharmacologic regimens for hypercholesterolemia.
Topics: Adult; Aged; Cholestyramine Resin; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hyperlipoproteinemia Type II; Lovastatin; Male; Middle Aged; Naphthalenes; Neomycin; Niacin; Retrospective Studies | 1987 |
[Drugs in hyperlipidemia].
Topics: Cholestyramine Resin; Clofibrate; Humans; Hypercholesterolemia; Hyperlipidemias; Hyperlipoproteinemias; Hypolipidemic Agents; Neomycin; Niacin | 1987 |
Lipid-lowering drugs.
Topics: Anticholesteremic Agents; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Gemfibrozil; Humans; Hypolipidemic Agents; Lipoproteins; Neomycin; Niacin; Pentanoic Acids; Probucol; Triglycerides | 1985 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |
[Isonicotinic acid and its association with soframycin].
Topics: Anti-Bacterial Agents; Antibiotics, Antitubercular; Dermatologic Agents; Framycetin; Isomerism; Isonicotinic Acids; Niacin; Nicotinic Acids | 1953 |
[Experimental study in vivo of isonicotinic acid hydrazide with various antibacillary substances (streptomycin, PAS, sulfones, neomycin, soframycin)].
Topics: Aminosalicylic Acid; Anti-Bacterial Agents; Antibiotics, Antitubercular; Framycetin; Isoniazid; Neomycin; Niacin; Nicotinic Acids; Streptomycin; Sulfones | 1953 |
[Action of isoniazid alone or with streptomycin sulfate or neomycin on Mycobacterium tuberculosis in vitro; influence on the appearance of resistant strains].
Topics: In Vitro Techniques; Isoniazid; Mycobacterium tuberculosis; Neomycin; Niacin; Nicotinic Acids; Streptomycin | 1953 |
Lowering of serum lipid concentrations: mechanisms used by unsaturated fats, nicotinic acid, and neomycin: excretion of sterols and bile acids.
Topics: Bile Acids and Salts; Diet; Fats; Fats, Unsaturated; Humans; Lipids; Neomycin; Niacin; Nicotinic Acids; Nutrition Assessment; Nutritional Status; Sterols | 1960 |
[Contribution to preventive cardiology].
Topics: Coronary Disease; Diet; Fats, Unsaturated; Heparin; Hypercholesterolemia; Ion Exchange Resins; Neomycin; Niacin; Nicotinic Acids; Thyroid Hormones | 1963 |
COMPARATIVE PHYSIOLOGY OF ANTIBIOTIC-RESISTANT STRAINS OF STAPHYLOCOCCUS AUREUS.
Topics: Anti-Bacterial Agents; Chloramphenicol; Coagulase; Drug Resistance, Microbial; Erythromycin; Glucose; Humans; Hydrolases; Mannitol; Metabolism; Micrococcus; Neomycin; Niacin; Nicotinic Acids; Novobiocin; Oleandomycin; Penicillins; Pyruvates; Research; Staphylococcal Infections; Staphylococcus; Staphylococcus aureus; Streptomycin; Tetracycline; Thiamine | 1963 |
BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. I. RESULTS OF INTRAVENOUS AND ORAL TRYPTOPHAN LOADING TESTS IN A CASE OF HARTNUP DISEASE.
Topics: Amino Acid Metabolism, Inborn Errors; Biomedical Research; Friedreich Ataxia; Genetics, Medical; Hartnup Disease; Humans; Indican; Indoles; Infant; Intestines; Metabolic Diseases; Neomycin; Niacin; Niacinamide; Nicotinic Acids; Nystatin; Pellagra; Renal Aminoacidurias; Tryptophan; Urine | 1964 |
BIOCHEMICAL ASPECTS OF THE HARTNUP DISEASE. II. SOME OBSERVATIONS ON RATS ABOUT TRYPTOPHAN METABOLISM.
Topics: Child; Clinical Enzyme Tests; Hartnup Disease; Humans; Indican; Indoles; Kidney; Kynurenine; Metabolic Diseases; Neomycin; Niacin; Niacinamide; Nicotinic Acids; Nystatin; Pellagra; Rats; Renal Aminoacidurias; Tryptophan; Urine | 1964 |
[DRUGS AGAINST HYPERCHOLESTEROLEMIA].
Topics: Adrenal Cortex Hormones; Arteriosclerosis; Estrogens; Gonadal Steroid Hormones; Heparin; Humans; Hypercholesterolemia; Lipid Metabolism; Neomycin; Niacin; Nicotinic Acids; Pyridoxine; Sterols; Thyroid Hormones; Triparanol | 1964 |
ACUTE CEREBELLAR ATAXIA ASSOCIATED WITH SOME FEATURES OF THE HARTNUP SYNDROME. PRESENTATION OF A CASE.
Topics: Amino Acid Metabolism, Inborn Errors; Cerebellar Ataxia; Child; Chromatography; Drug Therapy; Electroencephalography; Friedreich Ataxia; Hartnup Disease; Humans; Indoles; Italy; Neomycin; Niacin; Nicotinic Acids; Nystagmus, Pathologic; Renal Aminoacidurias; Tryptophan; Urine | 1964 |
THERAPY OF HYPERCHOLESTEROLEMIA.
Topics: Diet; Diet Therapy; Drug Therapy; Hypercholesterolemia; Neomycin; Niacin; Nicotinic Acids | 1964 |
Effect of oral administration of neomycin and oxytetracyclin on urinary excretion of thiamine, riboflavin, nicotinic acid, pantothenic acid and biotin in man.
Topics: Administration, Oral; Biotin; Folic Acid; Humans; Male; Neomycin; Niacin; Nicotinic Acids; Oxytetracycline; Pantothenic Acid; Riboflavin; Thiamine; Vitamin B Complex | 1961 |